Concepedia

Peihua Lu

PL

32

Publications

1.9K

Citations

19

H-Index

1994

Active since

Affiliations

Beijing Dao Pei Hospital(Current)

Peking University People's Hospital

Peking University

Institute of Hematology & Blood Diseases Hospital

Luye Pharma (China)

Peihua Lu is an author at Beijing Dao Pei Hospital specializing in medicine, immunology, and hematology.

ORCID

Top concepts

Publications per year

1994–2024

32

Publications

32

A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency.

Peihua Lu, Robert S. Negrin · The Journal of Immunology · 1994 · 432 citations

High efficacy and safety of low-dose CD19-directed CAR-T cell therapy in 51 refractory or relapsed B acute lymphoblastic leukemia patients

Jing Pan, Jieyu Yang, Biping Deng et al. · Leukemia · 2017 · 231 citations

, , +6

Efficacy and safety of anti-CD19 CAR T-cell therapy in 110 patients with B-cell acute lymphoblastic leukemia with high-risk features

Xian Zhang, Xin‐an Lu, Junfang Yang et al. · Blood Advances · 2020 · 206 citations · Full text

, , +15

Efficacy and Safety of CD28- or 4-1BB-Based CD19 CAR-T Cells in B Cell Acute Lymphoblastic Leukemia

Xiangyu Zhao, Junfang Yang, Xian Zhang et al. · Molecular Therapy — Oncolytics · 2020 · 117 citations · Full text

Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in Hepatocellular Carcinoma

Luan Sun, Fang Gao, Zhanhui Gao et al. · Journal for ImmunoTherapy of Cancer · 2021 · 102 citations · Full text

Rows per page

1–5 of 32